Sun Pharmaceutical’s $576 Million Acquisition of Concert Pharmaceuticals

Davis Polk advised Sun Pharmaceutical, and Goodwin Procter advised Concert Pharmaceuticals.Sun Pharmaceutical Industries Limited announced its acquisition of Concert Pharmaceuticals Inc., through a tender offer for an upfront…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Pietro Martinoia

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here